Financials
Value Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 126.85 K225.75 K551.34 K454.1 K 1.36 M Research & development ———— — Operating income -291.82 K-1.88 M-778.76 K-224.05 K -3.18 M Non-Operating Income, Total -204.38 K527.29 K-808.19 K-215.9 K -701.18 K Interest expense, net of interest capitalized 22.27 K57.94 K3 1376 213 89.56 K Non-Operating Income, excl. Interest Expenses -226.66 K469.36 K-811.33 K-222.11 K -790.74 K Unusual income/expense ———— — Pretax income -496.21 K-1.36 M-1.59 M-439.94 K -3.88 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -496.21 K-1.36 M-1.59 M-439.94 K -3.88 M Discontinued operations ———— — Net income -496.21 K-1.36 M-1.59 M-439.94 K -3.88 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -496.21 K-1.36 M-1.59 M-439.94 K -3.88 M Basic earnings per share (Basic EPS) -0.03-0.09-0.1-0.03 -0.25 Diluted earnings per share (Diluted EPS) -0.03-0.09-0.1-0.03 -0.25 Average basic shares outstanding 14.87 M29.12 M15.45 M16.97 M — Diluted shares outstanding 14.87 M29.12 M15.45 M16.97 M — EBITDA ——-778.76 K— — EBIT -291.82 K-1.88 M-778.76 K-224.05 K -3.18 M Cost of revenue 72.59 K101.17 K47.86 K70.48 K 292.09 K Other cost of goods sold ———— — Depreciation & amortization (cash flow) ——0— —